Can ibogaine treat other conditions?

Evidence level: C Emerging evidence — observational studies and case series, no randomised controlled trials yet. We say so wherever it matters.

Ibogaine attracts a great deal of speculation. Search for almost any condition alongside its name and you will find someone claiming it helps — Parkinson’s disease, nicotine addiction, gambling, OCD, chronic pain, autoimmune conditions.

Most of those claims have no clinical evidence behind them. Some have a plausible mechanism and no data. A few describe things that would actually rule you out of treatment rather than qualify you for it.

This page goes through them honestly. Where there is a rationale we say so; where there is nothing, we say that too — including for conditions we are regularly asked to arrange treatment for.

How to think about this

One pattern explains most of the confusion.

Ibogaine acts on an unusually wide range of receptor systems, and it produces effects — reduced compulsion, a prolonged introspective state, reported changes in outlook — that are broad rather than specific. It is therefore easy to construct a plausible-sounding argument for almost any condition involving compulsion, mood or neurological function.

Plausible arguments are not evidence. Ibogaine’s clinical evidence base is small and concerns substance dependence: the published studies covered alcohol, cannabis, cocaine and crack. Everything beyond that is extrapolation, and the further you go from dependence, the thinner it becomes.

Ibogaine research →

Condition by condition

ConditionStatusWhat we would say
Nicotine / smokingRationale, no evidenceIbogaine acts on nicotinic receptors among others, so the mechanism is arguable. There is no clinical evidence for it as a smoking-cessation treatment, and we would not recommend travelling for that purpose alone. Notably, patients are asked not to smoke around treatment.
Gambling, gaming, compulsive behavioursTreated by some clinics; evidence thinThe reasoning is by analogy with substance compulsion, and some programmes accept these patients. Published outcome data does not exist. Reasonable to discuss; not something to expect certainty about.
Eating disordersCase by case; cautionCompulsive component makes the analogy tempting, but eating disorders carry their own medical risks — particularly electrolyte disturbance, which is directly relevant to cardiac safety. Requires specialist assessment, not enthusiasm.
OCDMinimal dataOccasional interest, no meaningful clinical evidence. Established treatments should come first.
Depression, PTSD, traumaEarly researchThe most active area outside addiction. Strongest where it accompanies dependence. See the full page →
Traumatic brain injuryEarly researchStudies in veterans have reported symptom improvements, but the work is early and we make no claims about treating TBI. See veterans page →
Parkinson’s diseaseExclusion criterionFrequently asked about because of preclinical interest in neuroplasticity. In the published treatment protocol, Parkinson’s disease is an explicit exclusion — patients with it are not treated.
Alzheimer’s / dementiaExclusion criterionAlso an explicit exclusion in the published protocol.
Bipolar disorderCaution / usually excludedA risk consideration rather than an indication. Psychosis and schizophrenia are contraindications without exception.
Epilepsy / seizure disordersSerious cautionRequires specialist assessment; seizure history is a significant complicating factor, not a target.
DiabetesExclusion if uncontrolledUncontrolled diabetes is an explicit exclusion criterion — controlling it is a prerequisite, not a treatment goal.
ALS, multiple sclerosis, autoimmune conditionsNo basisNo clinical evidence supports ibogaine for these. We do not arrange treatment on this basis.
Chronic pain, fibromyalgiaNo basisOccasionally claimed, not supported. Where opioid dependence has developed from pain management, the dependence is the treatable part.
Lyme disease, “parasites”, cancer, long COVIDNo basisNo evidence whatsoever. Any provider offering ibogaine for these is one to avoid entirely.

The Parkinson's paradox

One entry above deserves expanding, because it illustrates the whole problem.

“Does ibogaine treat Parkinson’s disease?” is among the most common questions we receive in this category. The interest is not baseless: there is preclinical research into whether ibogaine promotes neuroplasticity and affects neurotrophic factors, and that research is legitimately interesting.

But in the published clinical protocol, Parkinson’s disease is an exclusion criterion — patients with it are not accepted for treatment.

The gap between a laboratory hypothesis and a treatment a person can safely receive is the entire distance this field has to travel. Preclinical promise is a reason to fund research. It is not a reason to fly somewhere and take a compound with cardiac risks for a condition nobody has shown it treats.

When "other conditions" are really the same condition

A significant number of enquiries in this category turn out to describe dependence wearing different clothes.

Someone asking about ibogaine for chronic pain is often dependent on the opioids prescribed for it. Someone asking about anxiety has frequently been drinking to manage it for years. Someone asking about “compulsive behaviour” describes a pattern that includes a substance.

Where that is the case, the picture changes: dependence is what ibogaine has actually been studied for, and there is real ground to stand on.

This is worth raising when you contact us — not because we are trying to reframe your problem, but because the honest answer often differs depending on which of these is underneath.

Why we say no

We are not a clinic, and we keep the list of conditions we help with short on purpose: there is a strong ethical reason not to expand it.

So we decline enquiries regularly, including from people who are willing to pay and want to proceed. If someone travels for a condition ibogaine has never been shown to treat, they take on a genuine cardiac risk for no expected benefit, and lose money and time they may not have.

A clinic that treats everything treats nothing carefully. The same applies to advisories.

How to choose an ibogaine clinic →

If your condition isn't listed

Ask us. We will tell you what is actually known — including, most of the time, that the honest answer is “there is no evidence for that, and we would not recommend it”.

If dependence is part of the picture, we will say that too, and explain what treatment would realistically involve.

Ask about your specific situation

Free and confidential. We’ll give you the honest position, including when the answer is no — usually within 24 hours.

Sources

  1. Schenberg EE, de Castro Comis MA, Chaves BR, da Silveira DX. Treating drug dependence with the aid of ibogaine: a retrospective study. Journal of Psychopharmacology. 2014;28(11):993–1000. doi:10.1177/0269881114552713
  2. Cherian KN, Keynan JN, Anker L, et al. Magnesium–ibogaine therapy in veterans with traumatic brain injuries. Nature Medicine. 2024;30(2):373–381. doi:10.1038/s41591-023-02705-w

Frequently asked questions

01. Does ibogaine treat Parkinson's disease?
No. Despite preclinical interest in neuroplasticity, Parkinson's disease is an explicit exclusion criterion in the published treatment protocol.
02. Does ibogaine help with nicotine addiction?
There is a mechanistic rationale but no clinical evidence. We would not recommend travelling for smoking cessation alone.
03. Can ibogaine treat gambling addiction?
Some clinics accept behavioural addictions by analogy with substance dependence, but published outcome data does not exist.
04. Is ibogaine safe with bipolar disorder?
Bipolar disorder is a caution and frequently an exclusion; psychosis and schizophrenia are contraindications without exception.
05. Does ibogaine help chronic pain?
There is no evidence for it. Where opioid dependence has developed from pain treatment, the dependence is the part that can be addressed.
06. Can ibogaine treat ALS or multiple sclerosis?
No. No clinical evidence supports this, and we do not arrange treatment on that basis.
07. Why do some clinics offer ibogaine for many conditions?
Because ibogaine is unregulated and there is nothing stopping them. Breadth of claimed indications is a warning sign, not a strength.

This page is for information only and is not medical advice. Ibogaine is not an approved treatment for any condition, and the absence of evidence for a use is not a reason to try it privately.

Get a free, confidential assessment

Our consultation is free for you. Medical decisions are made by the clinic's doctors.